A recent study uncovered that PARK2, an E3 ubiquitin ligase implicated in Parkinson disease, could regulate Hippo/Yap signaling in esophageal squamous cell carcinoma (ESCC) (Zhou et al., 2020). This evidence concerns the gene PRKN and Parkinson disease.